Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  AFT Pharmaceuticals Limited    AFT   NZAFTE0001S4


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

RLG:Kiwi Health Flagship Store Launch in China-Tmall GlobalOpens in a new Window

10/21/2020 | 06:50pm EST

22 October 2020

Kiwi Health Flagship Store Launches in China on Tmall Global

  • ASX-listedRooLife (ASX:RLG) and ASX and NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) have officially launched the New Zealand branded online health and pharmacy store in China - "Kiwi Health"
  • "Kiwi Health" is the online marketplace in China for AFT Pharmaceuticals' high- profile, well-known and trusted portfolio of health and wellbeing products
  • Kiwi Health Store operated by RooLife launched on Alibaba's Tmall Global platform with the support of New Zealand Trade & Enterprise (NZTE)
  • Kiwi Health Store launched in preparation for Alibaba's 11.11 Global Shopping Festival to be held on 11 November

22 October 2020, Auckland - RooLife Group (ASX:RLG) and AFT Pharmaceuticals (ASX:AFP, NZX:AFT) have launched Kiwi Health, a New Zealand-brandedhealth and well-beingstore on Alibaba's Tmall Global marketplace, (as advised to the ASX on 10 July 2020) with the support of Alibaba Group and New Zealand Trade and Enterprise (NZTE).

The Kiwi Health store, launched in advance of and in preparation for Alibaba's 11.11 Global Shopping Festival, markets and sells a range of health and well-being products online in China. The store aims to leverage the strong brand awareness of AFT's product range under the "Kiwi's thinking about health" branding and the regard for New Zealand products in China.

AFT Pharmaceuticals Founder and CEO, Dr Hartley Atkinson, said the launch of the Tmall Global store was an important step in growing the company's reach to consumers in China, "Our products have already secured a strong following with the local Chinese consumers living in New Zealand and Australia. We believe the launch of our Tmall Global flagship store will further assist us in amplifying our online presence in the world's largest e-commerce market."

Alibaba Group's Managing Director in Australia and New Zealand, Maggie Zhou, said the time was right for New Zealand brands to think about expanding their reach in the China market: "We are delighted to see the launch of the Kiwi Health Tmall Global Flagship Store. New

Zealand products have a strong reputation and remain a popular choice with consumers in China who care more about their health and wellness than ever before."

The Kiwi Health Store project is also supported by New Zealand Trade and Enterprise (NZTE), the New Zealand government's international business development agency.

New Zealand Trade and Enterprise's General Manager Customers, Lisa Thompson commented, "COVID-19 has accelerated the importance of having a strong digital strategy, so exporters can meet their consumers where and however they shop. We are really pleased to be working alongside AFT Pharmaceuticals in this space. It is fantastic to see them set up their flagship store on TMall and we hope it is the beginning of ongoing success."

RooLife Managing Director, Bryan Carr added, "Working with AFT Pharmaceuticals is a fantastic outcome and opportunity for all involved. We look forward to marketing and selling their well- known, trusted portfolio of health and wellbeing products in the Chinese market on Alibaba's Tmall Global marketplace and also acknowledge and recognise the support provided by Alibaba Group and New Zealand Trade and Enterprise."

We have seen the successes achieved by large Australian and New Zealand based pharmacy chains online in China and we are excited by the opportunity to leverage the high regard for New Zealand and its products with Chinese shoppers."

RooLife provides the digital marketing, store operation and product distribution that drives sales of AFT Pharmaceuticals products on the Alibaba's Tmall Global platform. As China's largest cross-border marketplace, Tmall Global is the premier channel through which overseas brands and retailers can reach Chinese consumers, build brand awareness and gain valuable consumer insights in forming their overall China strategy, without the need for physical operations in China.

Kiwi Health Tmall Store Launched on Alibaba - "Kiwi's thinking about health"

Hosted annually on November 11, Alibaba's 11.11 Global Shopping Festival is the world's largest online shopping event in terms of the number of consumers and merchants participating during the event, with Kiwi Health Store planning a series of promotions to Chinese consumers during the Festival.

Kiwi Health Official Launch Event held at AFT Pharmaceuticals Auckland attended by Hartley Atkinson

  • CEO - AFT Pharmaceuticals, Pier Smulders, Country Manager, New Zealand, Alibaba Group, Lisa Thompson - General Manager NZ Customer - NZTE and Bryan Carr - CEO - RooLife Group (ZOOM).


Issued by: RooLife Group Ltd

Authorised by: The Board of RooLife Group Ltd

For further information, please visit the RooLife website at www.roolifegroup.com.au and www.aftpharm.com or contact:

Bryan Carr

Peter Nesveda

Managing Director

Corporate Affairs & International Investor Relations

Ph: +61 8 6444 1702

Ph: +61 412 357 375

Email: ir@roolifegroup.com.au


About RooLife Group Ltd (ASX:RLG)


The RooLife Group of companies provides fully integrated digital marketing and customer acquisition services focusing on driving online sales of products and services for its clients. With a key focus on driving sales in Australia and China the company's online e-Commerce marketplace assists businesses to sell directly to Chinese consumers and accept payment via the Alipay mobile payments platforms. RooLife's key positioning is about knowing and remaining connected with Chinese consumers, allowing brands to continually sell products to Chinese consumers based on their profiles and purchasing behaviours.

About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)


AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT Pharmaceutical's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.

About Alibaba Group



We enable businesses to transform the way they market, sell and operate and improve their efficiencies. We provide the technology infrastructure and marketing reach to help merchants, brands and other businesses to leverage the power of new technology to engage with their users and customers and operate in a more efficient way. Our businesses are comprised of core commerce, cloud computing, digital media and entertainment, and innovation initiatives. In addition, Ant Group, an unconsolidated related party, provides payment services and offers financial services for consumers and merchants on our platforms.

About New Zealand Trade and Enterprise


New Zealand Trade and Enterprise (NZTE) is the government agency charged with helping New Zealand businesses to grow internationally. We use our extensive knowledge and global networks to help exporters of all sizes make better decisions and connect to the right partners and investors.

This is an excerpt of the original content. To continue reading it, access the original document here.


AFT Pharmaceuticals Limited published this content on 22 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2020 22:49:06 UTC

© Publicnow 2020
01/18AFT PHARMACEUTICALS : 24-hour efficacy for Crystawash Extend Hand SanitiserOpens..
2020AFT PHARMACEUTICALS : AFP builds North American momentumOpens in a new Window
2020AFT PHARMACEUTICALS : AFP determination of Anita Baldauf independenceOpens in a ..
2020AFT PHARMACEUTICALS : Financial results for half year ended 30 september 2020
2020Aft Pharmaceuticals Posts Decline in Profit, Rise in Revenue for Six Months E..
2020AFT PHARMACEUTICALS : Opening european office, signs new partners for maxigesic ..
2020Aft Pharmaceuticals Opens Ireland Office
2020AFT PHARMACEUTICALS : AFP opening European office, signs new partners for MXGOpe..
2020AFT PHARMACEUTICALS : Welcomes us fda complete response letter
More news
Sales 2021 118 M 85,0 M 85,0 M
Net income 2021 11,7 M 8,40 M 8,40 M
Net Debt 2021 26,2 M 18,9 M 18,9 M
P/E ratio 2021 46,7x
Yield 2021 -
Capitalization 545 M 390 M 393 M
EV / Sales 2021 4,85x
EV / Sales 2022 4,01x
Nbr of Employees 86
Free-Float 28,2%
Duration : Period :
AFT Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AFT PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 3
Average target price 5,75 NZD
Last Close Price 5,24 NZD
Spread / Highest target 24,0%
Spread / Average Target 9,73%
Spread / Lowest Target -4,58%
EPS Revisions
Managers and Directors
Hartley Atkinson Chief Executive Officer, MD & Executive Director
David Mark Flacks Chairman
Malcolm Tubby Chief Financial Officer & Secretary
Douglas John Wilson Independent Non-Executive Director
Marree Atkinson Executive Director & Chief of Staff
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881